UnThreaded | Threaded | Whole Thread (24) | Ignore Thread Prev | Next
Author: steve203 Big funky green star, 20000 posts Top Recommended Fools Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 455747  
Subject: Re: Big Pharma attacks Maine Date: 11/12/2013 5:33 PM
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Recommendations: 5
In truth wouldn't it make more sense if everyone got the same price that is profitable for the company but doesn't rip off US customers?

It depends on what your definition of fair profit is.

As reasonably new drugs are protected from competition by patents, then, in theory, the sky is the limit for profits. Any "big gummit" national health program that uses it's monopoly power to negotiate prices for all the residents of it's country to counterbalance the drug maker's monopoly over supply is thus spun as evil.

The US media is full of industry propaganda about the evil socialist governments forcing us hard working USians to subsidize their drug supply. To hear them tell it, there are no drug companies outside of the US, because of oppressive socialist government policies...so, I guess AstraZeneca, Novartis and Sanofi are products of a deranged imagination.

Sniveling about the "safety" of USian patients is more anti-importation propaganda. As soon as the patents run out and compounds fall into generic territory, no one seems to care about product quality and safety.

Ranbaxy got USFDA nod with no or fraudulent data: Whistleblower Dinesh Thakur

Pointing out how test results were allegedly manipulated, he said: "When you find a blood sample rework for one patient copied 23 times because there are 24 patients needed to prove bioequivalence, that's not an error."


http://articles.economictimes.indiatimes.com/2013-11-07/news...

Ranbaxy whistleblower reveals how he exposed massive pharmaceutical fraud

in 2011, while one arm of the FDA was investigating Ranbaxy for serious criminal violations, another arm of the FDA was approving Ranbaxy for the exclusive rights to make the generic version of one of the most popular pharmaceuticals of all time: Lipitor. That decision by the FDA would earn the company a reported $600 million in the first six months.


http://www.cbsnews.com/8301-505263_162-57611023/ranbaxy-whis...

If this one Ranbaxy employee had not come forward, would the company have ever been investigated by the FDA?

Steve
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (24) | Ignore Thread Prev | Next

Announcements

Post of the Day:
Macro Economics

2.1: The Labor Pool Problem
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement